Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

Abstract Early relapse after platinum chemotherapy in epithelial ovarian cancer (EOC) portends poor survival. A‐priori identification of platinum resistance is therefore crucial to improve on standard first‐line carboplatin–paclitaxel treatment. The DNA repair pathway homologous recombination (HR) r...

Full description

Bibliographic Details

Published in:	EMBO Molecular Medicine
Main Authors:	Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn, Sai Srinivas Upadhyayula, Tuan Zea Tan, Stefanus Lie, Diana G Z Lim, Brendan N K Pang, Sherlly Lim, Joe P S Yeong, Anthony Karnezis, Derek S Chiu, Samuel Leung, David G Huntsman, Anna S Sedukhina, Ko Sato, Monique D Topp, Clare L Scott, Hyungwon Choi, Naina R Patel, Robert Brown, Stan B Kaye, Jason J Pitt, David S P Tan, Anand D Jeyasekharan
Format:	Article
Language:	English
Published:	Springer Nature 2021-03-01
Subjects:	HRD immune exclusion multiplexed IHC ovarian cancer RAD51
Online Access:	https://doi.org/10.15252/emmm.202013366